Lisa Nolan
2016
In 2016, Lisa Nolan earned a total compensation of $399.6K as Chief Business Officer at Rexahn Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $38,220 |
|---|---|
| Option Awards | $192,870 |
| Salary | $156,513 |
| Other | $12,024 |
| Total | $399,627 |
Nolan received $192.9K in option awards, accounting for 48% of the total pay in 2016.
Nolan also received $38.2K in non-equity incentive plan, $156.5K in salary and $12K in other compensation.
Rankings
In 2016, Lisa Nolan's compensation ranked 11,922nd out of 14,075 executives tracked by ExecPay. In other words, Nolan earned more than 15.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,922 out of 14,075 | 15th |
Division Manufacturing | 4,676 out of 5,489 | 15th |
Major group Chemicals And Allied Products | 1,669 out of 1,895 | 12th |
Industry group Drugs | 1,354 out of 1,538 | 12th |
Industry Pharmaceutical Preparations | 1,048 out of 1,176 | 11th |
Source: SEC filing on February 24, 2017.
Nolan's colleagues
We found three more compensation records of executives who worked with Lisa Nolan at Rexahn Pharmaceuticals in 2016.